The House FY 2026 FDA appropriations bill could force non-user fee program cuts to ensure minimum spending levels are met, agency sources told the Pink Sheet. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
